BIOMAT Database Logo BIOMAT Database Logo

Serum digoxin levels in adults with and without digoxin toxicity (a 86Rb uptake inhibition study). 1978

R K Bhalla, and A K Basu, and M L Bhatia

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D005260 Female Females
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

R K Bhalla, and A K Basu, and M L Bhatia
Serum digoxin estimation in adults by a non-RIA method (an 86Rb uptake inhibition study).
December 1983, The Journal of the Association of Physicians of India,
R K Bhalla, and A K Basu, and M L Bhatia
Serum levels and digoxin toxicity.
December 1981, JAMA,
R K Bhalla, and A K Basu, and M L Bhatia
Relationship between high serum digoxin levels and toxicity.
September 1997, International journal of clinical pharmacology and therapeutics,
R K Bhalla, and A K Basu, and M L Bhatia
Digoxin toxicity with normal digoxin and serum potassium levels: beware of magnesium, the hidden malefactor.
August 2013, The Journal of emergency medicine,
R K Bhalla, and A K Basu, and M L Bhatia
Digoxin toxicity in patients with high serum digoxin concentrations.
December 1987, The American journal of the medical sciences,
R K Bhalla, and A K Basu, and M L Bhatia
Quinidine enhances digitalis toxicity at therapeutic serum digoxin levels.
April 1993, Clinical pharmacology and therapeutics,
R K Bhalla, and A K Basu, and M L Bhatia
Digoxin visual toxicity with therapeutic blood levels of digoxin.
March 1998, American journal of ophthalmology,
R K Bhalla, and A K Basu, and M L Bhatia
A correlative study of serum digoxin levels with clinical tolerance.
August 1981, JPMA. The Journal of the Pakistan Medical Association,
R K Bhalla, and A K Basu, and M L Bhatia
The influence of metabolites of digoxin and digitoxin on the 86Rb-uptake assay.
June 1973, European journal of clinical pharmacology,
R K Bhalla, and A K Basu, and M L Bhatia
Proceedings: The influence of digoxin metabolites on 86Rb-uptake of human erythrocytes.
January 1975, Naunyn-Schmiedeberg's archives of pharmacology,
Copied contents to your clipboard!